Africa: Two New Candidate Vaccines to Join Ebola Trial As Treatment Research Advances

AllAfrica · 5 Nov 2026 · Health facility or pharma investment

[WHO] Expert groups convened by the World Health Organization (WHO) have recommended adding two new Ebola vaccine candidates to the ongoing Tumaini clinical trial in the Democratic Republic of the Congo (DRC). The recommendation marks the first time vaccines specifically designed to protect against Bundibugyo virus, the virus responsible for the current outbreak, will be evaluated during an outbreak of the disease.

Nurses, lab techs, biomedical equipment and facility operations